Raymond James Financial Services Advisors’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q3 | $27.5M | Sell |
52,801
-17,650
| -25% | -$9.18M | 0.04% | 430 |
|
2024
Q2 | $38.2M | Buy |
70,451
+1,409
| +2% | +$763K | 0.05% | 321 |
|
2024
Q1 | $35.8M | Sell |
69,042
-6,783
| -9% | -$3.52M | 0.05% | 334 |
|
2023
Q4 | $35.8M | Buy |
75,825
+5,954
| +9% | +$2.81M | 0.06% | 310 |
|
2023
Q3 | $30.4M | Buy |
69,871
+12,967
| +23% | +$5.65M | 0.06% | 319 |
|
2023
Q2 | $25.3M | Buy |
56,904
+5,861
| +11% | +$2.6M | 0.04% | 389 |
|
2023
Q1 | $23.5M | Buy |
51,043
+1,993
| +4% | +$916K | 0.04% | 394 |
|
2022
Q4 | $25.2M | Buy |
49,050
+191
| +0.4% | +$98K | 0.05% | 363 |
|
2022
Q3 | $22.2M | Sell |
48,859
-1,972
| -4% | -$896K | 0.05% | 364 |
|
2022
Q2 | $24.5M | Sell |
50,831
-267
| -0.5% | -$129K | 0.05% | 351 |
|
2022
Q1 | $25.1M | Buy |
51,098
+959
| +2% | +$471K | 0.05% | 377 |
|
2021
Q4 | $23.2M | Buy |
50,139
+6,101
| +14% | +$2.83M | 0.04% | 400 |
|
2021
Q3 | $16.4M | Buy |
44,038
+1,557
| +4% | +$581K | 0.03% | 500 |
|
2021
Q2 | $16.2M | Buy |
42,481
+1,447
| +4% | +$553K | 0.03% | 506 |
|
2021
Q1 | $14.7M | Buy |
41,034
+6,678
| +19% | +$2.4M | 0.03% | 481 |
|
2020
Q4 | $11M | Buy |
34,356
+77
| +0.2% | +$24.7K | 0.03% | 521 |
|
2020
Q3 | $9.21M | Buy |
34,279
+197
| +0.6% | +$52.9K | 0.03% | 531 |
|
2020
Q2 | $8.97M | Buy |
34,082
+655
| +2% | +$172K | 0.03% | 492 |
|
2020
Q1 | $7.59M | Sell |
33,427
-1,004
| -3% | -$228K | 0.03% | 438 |
|
2019
Q4 | $10.4M | Buy |
34,431
+4,601
| +15% | +$1.39M | 0.03% | 494 |
|
2019
Q3 | $7.16M | Buy |
29,830
+4,508
| +18% | +$1.08M | 0.03% | 566 |
|
2019
Q2 | $7.15M | Sell |
25,322
-7,347
| -22% | -$2.07M | 0.03% | 548 |
|
2019
Q1 | $9.38M | Buy |
32,669
+16,448
| +101% | +$4.72M | 0.04% | 444 |
|
2018
Q4 | $4.26M | Buy |
16,221
+3,299
| +26% | +$867K | 0.02% | 593 |
|
2018
Q3 | $3.54M | Sell |
12,922
-450
| -3% | -$123K | 0.02% | 784 |
|
2018
Q2 | $3.18M | Buy |
13,372
+3,122
| +30% | +$743K | 0.02% | 791 |
|
2018
Q1 | $2.25M | Buy |
10,250
+2,510
| +32% | +$551K | 0.01% | 876 |
|
2017
Q4 | $1.74M | Sell |
7,740
-1,766
| -19% | -$397K | 0.01% | 979 |
|
2017
Q3 | $1.81M | Buy |
9,506
+1,997
| +27% | +$379K | 0.01% | 968 |
|
2017
Q2 | $1.41M | Buy |
7,509
+735
| +11% | +$138K | 0.01% | 1051 |
|
2017
Q1 | $1.12M | Buy |
6,774
+978
| +17% | +$162K | 0.01% | 1108 |
|
2016
Q4 | $833K | Sell |
5,796
-857
| -13% | -$123K | 0.01% | 1221 |
|
2016
Q3 | $834K | Sell |
6,653
-197
| -3% | -$24.7K | 0.01% | 1192 |
|
2016
Q2 | $900K | Buy |
6,850
+328
| +5% | +$43.1K | 0.01% | 1099 |
|
2016
Q1 | $906K | Buy |
+6,522
| New | +$906K | 0.01% | 946 |
|